Topic Archive

Category: Uncategorized

Preanesthetic Medication

Introduction/Overview Background Preanesthetic medication constitutes the pharmacologic intervention administered prior to the induction of general or regional anesthesia. The primary objectives are…

Sedative‑Hypnotics: Benzodiazepines

Introduction / Overview Benzodiazepines constitute a widely used class of central nervous system (CNS) depressants that exert anxiolytic, hypnotic, anticonvulsant, and muscle‑relaxant…

Sedative‑Hypnotics: Barbiturates and Z‑drugs

Introduction / Overview Barbiturates and Z‑drugs represent two distinct classes of sedative‑hypnotics that have been widely employed to manage insomnia, anxiety, and…

Ethanol and Disulfiram

1. Introduction Definition and Overview Ethanol, the principal intoxicating agent in alcoholic beverages, is a small, volatile alcohol that exerts a broad…

Methanol Poisoning

Introduction Methanol, a simple aliphatic alcohol (CH₃OH), is widely used as a solvent, antifreeze, and raw material in the synthesis of formaldehyde.…

Hydantoins and Barbiturates for Epilepsy

Introduction Definition and Overview The term “hydantoin” refers to a class of heterocyclic compounds containing a 5,5-dihydro-1,3-diazin-2-one core. Within this chemical scaffold,…

Iminostilbenes (Carbamazepine) and Valproate: Pharmacology, Clinical Applications, and Case-Based Learning

Introduction Definition and Overview Carbamazepine and valproate represent two cornerstone agents in the management of epilepsy, bipolar disorder, and various neuropathic pain…

Untitled Article

References Golan DE, Armstrong EJ, Armstrong AW. Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. 4th ed. Philadelphia: Wolters Kluwer; 2017.…

Drugs for Parkinson’s Disease (Levodopa/Carbidopa)

1. Introduction/Overview Parkinson’s disease (PD) represents a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars…

Dopamine Agonists and MAO‑B Inhibitors for Parkinson’s Disease

1. Introduction/Overview Parkinson’s disease (PD) is a progressive neurodegenerative disorder primarily characterized by the loss of dopaminergic neurons within the substantia nigra…